Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness may keep women in addiction treatment longer

NCT ID NCT02977988

Disease control Sponsor: University of Southern California Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a mindfulness program designed for women in residential treatment for substance use disorders. The program, called Mindfulness-Based Relapse Prevention for Women (MBRP-W), teaches stress management skills to help women stay in treatment and avoid relapse. Researchers enrolled 200 women and measured treatment completion and drug use after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mindfulness meditation program (Mindfulness-Based Relapse Prevention for Women)
What this could lead to
If it works, this could offer a practical, low-cost tool to help women with substance use disorders stay in treatment and reduce relapse risk.
What could go wrong
This is a completed study, but it's small and focused on a specific group (low-income women in residential treatment). Results may not apply to everyone, and the benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Oct 2015

Finished

Jun 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for parent study: * Female * Adult in California (18 years or older) * Diagnosed with a substance use disorder (SUD) * Speaks fluent English * Client at study site, substance use disorder residential facility at time of recruitment Exclusion criteria for parent study: * Inability to comprehend informed consent * Unwilling to sign informed consent * Cognitive impairment, psychotic disorder or severe chronic mental health condition based on clinical intake DSM-V assessment * Older than 65 years of age * Reported suicidality in last 30 days * Current prisoner * Pregnant in the 3rd trimester * Pregnant (MRI subsample only) * Not willing to be audio recorded * Not willing to have data stored for research purposes Additional exclusion criteria for brain imaging sub-study: * Older than 50 years of age * Not in good general health * Left handed (with a mean item score \>1 on the handedness scale) * Currently pregnant * Current medical devices (cardiac pacemaker, implanted cardiac defibrillator, carotid artery vascular clamp, neurostimulator, cochlear implant, metal fragments (including shrapnel) in the head, eyes, or skin, vascular stent, ocular implant, penile implant, vascular filter for clots (including Greenfield, Umbrella, or Birds Nest filters) * Other non-removable devices (IUD, dental braces or retainer, piercings that cannot be removed prior to resting, permanent eye-liner) * Body Mass Index (BMI) greater than 36 * History of head trauma resulting in loss of consciousness for more than 5 minutes * Documented or subjectively reported claustrophobia * Having hair extensions or a wig connected by wire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Substance-related disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior, Addictive substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Substance-related disorders

Contacts and locations

Locations

  • Prototypes' Pomona Women's Center

    Pomona, California, 91767, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.